Fragment-Based Drug Discovery

Fragment-Based Drug Discovery
Author :
Publisher : John Wiley & Sons
Total Pages : 296
Release :
ISBN-10 : 9780470721568
ISBN-13 : 0470721561
Rating : 4/5 (561 Downloads)

Book Synopsis Fragment-Based Drug Discovery by : Edward R. Zartler

Download or read book Fragment-Based Drug Discovery written by Edward R. Zartler and published by John Wiley & Sons. This book was released on 2008-11-20 with total page 296 pages. Available in PDF, EPUB and Kindle. Book excerpt: Fragment-based drug discovery (FBDD) is a new paradigm in drug discovery that utilizes very small molecules - fragments of larger molecules. It is a faster, cheaper, smarter way to do drug discovery, as shown by the number of pharmaceutical companies that have embraced this approach and the biotechnology companies who use fragments as their sole source of drug discovery. Fragment-Based Drug Discovery: A Practical Approach is a guide to the techniques and practice of using fragments in drug screening. The emphasis is on practical guidance, with procedures, case studies, practical tips, and contributions from industry. Topics covered include: an introduction to fragment based drug discovery, why using fragments is a more efficient process than predominant models, and what it means to have a successful FBDD effort. setting up an FBDD project library building and production NMR in fragment screening and follow up application of protein-ligand NOE matching to the rapid evaluation of fragment binding poses target immobilized NMR screening: validation and extension to membrane proteins in situ fragment-based medicinal chemistry: screening by mass spectrometry computational approaches to fragment and substructure discovery and evaluation virtual fragment scanning: current trends, applications and web based tools fragment-based lead discovery using covalent capture methods case study from industry: the identification of high affinity beta-secretase inhibitors using fragment-based lead generation With contributions from industry experts who have successfully set up an industrial fragment-based research program, Fragment-Based Drug Discovery: A Practical Approach offers essential advice to anyone embarking on drug discovery using fragments and those looking for a new approach to screening for drugs.


Fragment-Based Drug Discovery Related Books

Fragment-Based Drug Discovery
Language: en
Pages: 296
Authors: Edward R. Zartler
Categories: Science
Type: BOOK - Published: 2008-11-20 - Publisher: John Wiley & Sons

DOWNLOAD EBOOK

Fragment-based drug discovery (FBDD) is a new paradigm in drug discovery that utilizes very small molecules - fragments of larger molecules. It is a faster, che
Fragment-based Drug Discovery
Language: en
Pages: 524
Authors: Daniel A. Erlanson
Categories: Medical
Type: BOOK - Published: 2016-02-23 - Publisher: John Wiley & Sons

DOWNLOAD EBOOK

From its origins as a niche technique more than 15 years ago, fragment-based approaches have become a major tool for drug and ligand discovery, often yielding r
Fragment-Based Drug Discovery
Language: en
Pages: 314
Authors: Steven Howard
Categories: Medical
Type: BOOK - Published: 2015-06-17 - Publisher: Royal Society of Chemistry

DOWNLOAD EBOOK

Fragment-based drug discovery is a rapidly evolving area of research, which has recently seen new applications in areas such as epigenetics, GPCRs and the ident
Fragment Based Drug Design
Language: en
Pages: 662
Authors: Lawrence C. Kuo
Categories: Medical
Type: BOOK - Published: 2011-03-09 - Publisher: Academic Press

DOWNLOAD EBOOK

There are numerous excellent reviews on fragment-based drug discovery (FBDD), but there are to date no hand-holding guides or protocols with which one can embar
Fragment-Based Drug Discovery and X-Ray Crystallography
Language: en
Pages: 235
Authors: Thomas G. Davies
Categories: Science
Type: BOOK - Published: 2012-01-23 - Publisher: Springer Science & Business Media

DOWNLOAD EBOOK

Introduction to Fragment-Based Drug Discovery, by Daniel A. Erlanson Fragment Screening Using X-Ray Crystallography, by Thomas G. Davies and Ian J. Tickle Hsp90